Atlas Trials

Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions

Clinical trial NCT03553875 · TERMINATED

Trial details

NCT number
NCT03553875
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
AutismAutism Spectrum DisorderNonverbal Learning Disability
Start date
2018-11-13
Primary completion
2025-11-25
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.